{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:03:40Z","timestamp":1790165020801,"version":"4.1.0"},"reference-count":50,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Thrombophilia testing is commonly performed after venous thromboembolism (VTE), yet its clinical value is frequently overestimated. This narrative critical review synthesizes key observational studies, systematic reviews, and contemporary clinical practice guidelines addressing the utility, timing, and management implications of thrombophilia testing after VTE, as well as in related clinical settings where analogous testing decisions arise such as cryptogenic arterial stroke and recurrent pregnancy loss. Evidence and recommendations were selected based on their clinical relevance to anticoagulation decisions, recurrence risk assessment, and patient-specific management, with particular attention to contemporary guidelines from the American Society of Hematology, American College of Chest Physicians, National Institute for Health and Care Excellence, and British Society for Haematology. The strength and certainty of the evidence underlying these recommendations were also considered, recognizing that several recommendations are conditional and are supported by very low certainty evidence and decision modeling. Overall, the available evidence synthesized in this review indicates that anticoagulation decisions are determined primarily by whether the event was provoked or unprovoked, the risks of recurrence and bleeding, and patient-specific clinical factors rather than by the presence of most inherited thrombophilias. Although thrombophilia testing often identifies laboratory abnormalities, it rarely changes clinical management while increasing healthcare costs and the potential for unnecessary treatment and patient anxiety. Antiphospholipid syndrome remains the major exception because its diagnosis directly influences anticoagulant selection, treatment duration, and pregnancy management. This review also considers the importance of appropriate test timing, the effects of anticoagulant therapy on test interpretation, and the role of thrombophilia testing in selected clinical scenarios. Based on the available evidence, we propose a practical, management-oriented approach in which testing is reserved for situations where the results are expected to influence therapeutic decision making, thereby promoting high-value, evidence-based patient care.<\/jats:p>","DOI":"10.3390\/jcm15197393","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:09:08Z","timestamp":1790161748000},"page":"7393","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thrombophilia Testing After VTE and in Related Clinical Contexts: Is It Necessary, and Does It Change Management? Appraisal of Evidence, Guidelines, and Clinical Yield"],"prefix":"10.3390","volume":"15","author":[{"given":"Riwad","family":"Iftekhar","sequence":"first","affiliation":[{"name":"School of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emory","family":"Ware","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilee","family":"Ly","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad I.","family":"Ullah","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMra1700365","article-title":"Thrombophilia Testing and Venous Thrombosis","volume":"377","author":"Connors","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1055\/s-0040-1714334","article-title":"Clinical Utilization and Cost of Thrombophilia Testing in Patients with Venous Thromboembolism","volume":"04","author":"Gaddh","year":"2020","journal-title":"TH Open"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Shen, Y.-M., Tsai, J., Taiwo, E., Gavva, C., Yates, S.G., Patel, V., Frenkel, E., and Sarode, R. (2016). Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155326"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tracli.2025.03.004","article-title":"Comprehensive Review of Thrombophilia: Pathophysiology, Prevalence, Risk Factors, and Molecular Diagnosis","volume":"32","author":"Altwayan","year":"2025","journal-title":"Transfus. Clin. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/CIRCULATIONAHA.113.001943","article-title":"Inherited and Secondary Thrombophilia","volume":"129","author":"Cohoon","year":"2014","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2008-01-077909","article-title":"Advances in Understanding Pathogenic Mechanisms of Thrombophilic Disorders","volume":"112","year":"2008","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e069717","DOI":"10.1136\/bmj-2021-069717","article-title":"Antiphospholipid Syndrome: Advances in Diagnosis, Pathogenesis, and Management","volume":"380","author":"Knight","year":"2023","journal-title":"BMJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7326\/0003-4819-135-5-200109040-00008","article-title":"A Prospective Study of Asymptomatic Carriers of the Factor V Leiden Mutation To Determine the Incidence of Venous Thromboembolism","volume":"135","author":"Middeldorp","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-0037-1614442","article-title":"Incidence of Venous Thromboembolism in Families with Inherited Thrombophilia","volume":"81","author":"Simioni","year":"1999","journal-title":"Thromb. Haemost."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00125817-200103000-00009","article-title":"American College of Medical Genetics Consensus Statement on Factor V Leiden Mutation Testing","volume":"3","author":"Grody","year":"2001","journal-title":"Genet. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1001\/jama.2025.2420","article-title":"Factor V Leiden","volume":"333","author":"Martin","year":"2025","journal-title":"J. Am. Med. Assoc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1007\/s00277-024-05926-2","article-title":"Venous Thromboembolism Risk in Adults with Hereditary Thrombophilia: A Systematic Review and Meta-Analysis","volume":"103","author":"Alnor","year":"2024","journal-title":"Ann. Hematol."},{"key":"ref_13","first-page":"1271","article-title":"Risk of Venous Thrombosis in Carriers of the Prothrombin G20210A Variant and Factor V Leiden and Their Interaction with Oral Contraceptives","volume":"85","author":"Aznar","year":"2000","journal-title":"Haematologica"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0037-1615049","article-title":"Geographic Distribution of the 20210 G to A Prothrombin Variant","volume":"79","author":"Rosendaal","year":"1998","journal-title":"Thromb. Haemost."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/MOH.0000000000000861","article-title":"The Role of Germline and Somatic Mutations in Predicting Cancer-Associated Thrombosis: A Narrative Review","volume":"32","author":"Lanting","year":"2025","journal-title":"Curr. Opin. Hematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11239-011-0572-y","article-title":"Evidence-Based Approach to Thrombophilia Testing","volume":"31","author":"Middeldorp","year":"2011","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1055\/s-0040-1714100","article-title":"GFHT Study Group on Genetic Thrombophilia Genotype-Phenotype Relationships in a Large French Cohort of Subjects with Inherited Protein C Deficiency","volume":"120","author":"Mauge","year":"2020","journal-title":"Thromb. Haemost."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/01.ATV.19.4.1026","article-title":"Risk of Venous Thromboembolism and Clinical Manifestations in Carriers of Antithrombin, Protein C, Protein S Deficiency, or Activated Protein C Resistance: A Multicenter Collaborative Family Study","volume":"19","author":"Bucciarelli","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_19","first-page":"3702","article-title":"The Incidence of Venous Thromboembolism in Asymptomatic Carriers of a Deficiency of Antithrombin, Protein C, or Protein S: A Prospective Cohort Study","volume":"94","author":"Sanson","year":"1999","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1538-7836.2005.01308.x","article-title":"The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: A family cohort study","volume":"3","author":"Tormene","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.40901","article-title":"The Epidemiology of Antiphospholipid Syndrome: A Population-Based Study","volume":"71","author":"Pham","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.trsl.2020.04.006","article-title":"Antiphospholipid Syndrome","volume":"225","author":"Petri","year":"2020","journal-title":"Transl. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"108597","DOI":"10.1016\/j.clim.2020.108597","article-title":"Treatment of Antiphospholipid Syndrome","volume":"221","author":"Radin","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yang, L., Guo, R., Liu, H., Chen, B., Li, C., Liu, R., Liao, S., Xie, Q., and Yin, G. (2025). Mechanism of Antiphospholipid Antibody-Mediated Thrombosis in Antiphospholipid Syndrome. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1527554"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 Guidelines for Management of Venous Thromboembolism: Thrombophilia Testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.chest.2021.07.056","article-title":"Executive Summary","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"ref_27","unstructured":"National Institute for Health and Care Excellence (NICE) (2020). Venous Thromboembolic Diseases: Diagnosis, Management and Thrombophilia Testing, NICE. NICE Guideline NG158."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/bjh.18239","article-title":"Thrombophilia Testing: A British Society for Haematology Guideline","volume":"198","author":"Arachchillage","year":"2022","journal-title":"Br. J. Haematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/ijlh.12672","article-title":"Optimal Utilization of Thrombophilia Testing","volume":"39","author":"Pruthi","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/jth.13912","article-title":"Laboratory Testing in Patients Treated with Direct Oral Anticoagulants: A Practical Guide for Clinicians","volume":"16","author":"Douxfils","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.12788\/jhm.2804","article-title":"Patterns and Appropriateness of Thrombophilia Testing in an Academic Medical Center","volume":"12","author":"Cox","year":"2017","journal-title":"J. Hosp. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/jhm.2616","article-title":"Inpatient Inherited Thrombophilia Testing","volume":"11","author":"Petrilli","year":"2016","journal-title":"J. Hosp. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11239-015-1316-1","article-title":"Guidance for the Evaluation and Treatment of Hereditary and Acquired Thrombophilia","volume":"41","author":"Stevens","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1212\/CON.0000000000000833","article-title":"Ischemic Stroke in Young Adults","volume":"26","author":"Putaala","year":"2020","journal-title":"Continuum"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Berkman, S.A., and Song, S.S. (2021). Ischemic Stroke in the Young. Clin. Appl. Thromb., 27.","DOI":"10.1177\/10760296211002274"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.006","article-title":"Clinical Impact of Thrombophilia Screening in Young Adults with Ischemic Stroke","volume":"28","author":"Omran","year":"2019","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism: Venous Thromboembolism in the Context of Pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0961203317692432","article-title":"Pregnancy Failure in Patients with Obstetric Antiphospholipid Syndrome with Conventional Treatment: The Influence of a Triple Positive Antibody Profile","volume":"26","author":"Latino","year":"2017","journal-title":"Lupus"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 Guidelines for Management of Venous Thromboembolism: Prevention and Treatment in Patients with Cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv."},{"key":"ref_42","first-page":"426","article-title":"Anticoagulation: Updated Guidelines for Outpatient Management","volume":"100","author":"Wigle","year":"2019","journal-title":"Am. Fam. Physician"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.hlc.2025.05.092","article-title":"Modernising Acute PE and VTE Management: Meta-Analysis of Newer Anticoagulants Versus Traditional Therapy on Recurrence and Mortality","volume":"34","author":"Kotokey","year":"2025","journal-title":"Heart Lung Circ."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.jtha.2024.03.027","article-title":"Dilemmas in the Diagnosis and Management of Antiphospholipid Syndrome","volume":"22","author":"Manning","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jth.13336","article-title":"Categorization of Patients as Having Provoked or Unprovoked Venous Thromboembolism: Guidance from the SSC of ISTH","volume":"14","author":"Kearon","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/archinternmed.2010.367","article-title":"Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor: A Systematic Review","volume":"170","author":"Iorio","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"l4363","DOI":"10.1136\/bmj.l4363","article-title":"Long Term Risk of Symptomatic Recurrent Venous Thromboembolism after Discontinuation of Anticoagulant Treatment for First Unprovoked Venous Thromboembolism Event: Systematic Review and Meta-Analysis","volume":"366","author":"Khan","year":"2019","journal-title":"BMJ"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/bjh.15533","article-title":"Predictive Value of Venous Thromboembolism (VTE)-BLEED to Predict Major Bleeding and Other Adverse Events in a Practice-based Cohort of Patients with VTE: Results of the XALIA Study","volume":"183","author":"Klok","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation: The Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"CHEST"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Gu, Y., Yang, Y., Gao, X., Wang, Y., Yang, L., and Wei, Y. (2025). Application of Artificial Intelligence in Risk Assessment and Management of Venous Thromboembolism: Scoping Review. Front. Physiol., 16.","DOI":"10.3389\/fphys.2025.1664470"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7393\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:29:16Z","timestamp":1790162956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":50,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["jcm15197393"],"URL":"https:\/\/doi.org\/10.3390\/jcm15197393","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]}}}